Hybrid lipid–polymer particles are gaining increasing interest to be applied as drug delivery systems due
to their greater stability in biological
fluids and enhanced cellular uptake of drugs. However, a major
drawback is the fact that these particles are usually produced through techniques that use organic
solvents. This work studies the possibility of producing for the
first time hybrid particles composed by
lipid multicores enveloped in a polymeric layer through Particles from Gas Saturated Solutions (PGSS1),
without using organic solvents. An oil-in-water emulsion, composed by Gelucire 43/01TM (GEL) as the
discontinuous phase and by an aqueous polyethylene glycol 4000 (PEG) solution as the continuous phase,
was successfully precipitated by PGSS1. Operating conditions that ensured the stability of the CO2
saturated emulsion were previously evaluated. The resulting PEG–GEL particles present a spherical-like
morphology constituted by several lipid cores encapsulated into a polymeric shell. The applicability of
these structured particles to be used as drug delivery system (DDS) was studied by using ketoprofen, a
nonsteroidal anti-inflammatory drug (NSAID), as model drug. The particles provided an initial burst
release of the drug due to the progressive dissolution of the external layer of PEG, followed by a controlled
release of the NSAID from the GEL cores
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.